Black Hawk Acquisition Corporation

BKHA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024
Operating Activities
Net Income $1.3M $1.9M
Depreciation & Amortization — —
Depreciation — —
Amortization — —
Stock-Based Compensation — —
Net Cash from Operating Activities $-650.3K $-553.7K
Investing Activities
Capital Expenditures — —
Business Acquisitions — —
Net Cash from Investing Activities $50.3M $-69.3M
Financing Activities
Dividends Paid — —
Stock Repurchases — —
Net Cash from Financing Activities $-49.8M $70.0M
Net Change in Cash — —
Free Cash Flow — —